KWANGDONG PHARMACEUTICAL CO.,LTD
Kwangdong Pharmaceutical, founded in 1963 and KOSPI-listed in 1989, manufactures prescription drugs and beverages.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1963 and listed on KOSPI in 1989, Kwangdong Pharmaceutical manufactures and sells prescription drugs and food and beverage products. It operates a roughly 15,000-pyeong food plant in Jangdang-dong, Pyeongtaek, and a roughly 3,000-pyeong GMP plant in Mogok-dong, Pyeongtaek, with some products manufactured via OEM. 98.6% of its revenue comes from the domestic market; it has no license-out agreements but has license-in agreements in place.
Regulatory approvals
data.go.kr319 Korean MFDS drug approvals · 1963–2026 / 4 Korean MFDS device approvals · 1999–2014
- MFDS drugElfabrio injection(Pegunigalsidase alfa)2026-05-21Drug · Prescription · Approval202601480
- MFDS drugK-tinib Tablet 80mg (Osimertinib mesylate)2026-04-30Drug · Prescription · Approval202601294
- MFDS drugK-tinib Tablet 40mg (Osimertinib mesylate)2026-04-30Drug · Prescription · Approval202601295
- MFDS drugBromfenix Eye Drops2026-02-12Drug · Prescription · Approval202600427
- MFDS drugLamzede injection10mg(Velmanase alfa)2026-01-12Drug · Prescription · Approval202600088
- MFDS drugChondro Power1200 oral gel2025-12-11Drug · OTC · Notification202503258
- MFDS drugKwangdongcold S solution2025-06-24Drug · OTC · Notification202501561
- MFDS drugOLOnyx Eye Drops 0.7%2025-05-26Drug · Prescription · Approval202501293
- MFDS drugGearcare Tab.2025-05-08Drug · OTC · Approval202501129
- MFDS drugOLOnyx Eye Drops 0.2%2025-04-30Drug · Prescription · Approval202501057
- MFDS drugMy Mg Double Care Solution2025-04-24Drug · OTC · Notification202500979
- MFDS drugBalentok Nail Lacquer2025-04-07Drug · OTC · Notification202500819
Show 68 more
- MFDS drugKwangdong Cal-D Tab.2025-03-18Drug · OTC · Notification202500617
- MFDS drugKwangdong L-Arginine Hydrochloride Bag Inj.2024-12-18Drug · Prescription · Approval202402996
- MFDS drugEYETOK Duo eye drops2024-06-25Drug · OTC · Approval202401528
- MFDS drugJangi The Lac Capsule2024-03-26Drug · OTC · Notification202400655
- MFDS drugJangi The Lac Powder2024-03-26Drug · OTC · Notification202400656
- MFDS drugHardyCoPlus Tab.2023-11-27Drug · OTC · Notification202303224
- MFDS drugCoxduo tab.2023-08-10Drug · Prescription · Approval202302408
- MFDS drugEyetok CMC Eye Drops 1%2023-07-28Drug · OTC · Notification202302282
- MFDS drugKwangdong Povidone Iodine Gargle2023-07-07Drug · OTC · Approval202302073
- MFDS drugMymegaPlus Tab.2023-06-22Drug · OTC · Notification202301912
- MFDS drugEYETOK Cool eyedrops2023-05-26Drug · OTC · Notification202301685
- MFDS drug광동침옥고2023-05-11Drug · OTC · Approval202301522
- MFDS drugAlency Cap. 75mg2023-03-22Drug · Prescription · Approval202300993
- MFDS drugAlency Cap. 100mg2023-03-22Drug · Prescription · Approval202300994
- MFDS drugAlency Cap. 125mg2023-03-22Drug · Prescription · Approval202301001
- MFDS drugDacomsita Tablet 10/100mg2023-01-31Drug · Prescription · Approval202300417
- MFDS drugMagnophen Tab2023-01-11Drug · OTC · Notification202300204
- MFDS drugEYEPLE Clear eye drops.2022-12-16Drug · OTC · Notification202204515
- MFDS drugEYEPLE Blue eye drops.2022-12-16Drug · OTC · Notification202204516
- MFDS drugEYEPLE Cure eye drops2022-12-16Drug · OTC · Notification202204517
- MFDS drugDaprodi Tablet 5mg2022-12-05Drug · Prescription · Approval202204370
- MFDS drugKwangdong Chiol Paste(Hinokitiol)2022-11-18Drug · OTC · Approval202204148
- MFDS drugHadicol Q Tab.2022-10-07Drug · OTC · Notification202203789
- MFDS drugIFRISI Tablet2022-06-13Drug · Prescription · Approval202202479
- MFDS drugibuK injection(ibuprofen)2022-06-07Drug · Prescription · Approval202202347
- MFDS drugAmipartibag injection 3%2022-06-02Drug · Prescription · Notification202202325
- MFDS drugEsleesi Tab.2022-05-25Drug · Prescription · Approval202202234
- MFDS drugDaprodi Tablet 10mg2022-05-23Drug · Prescription · Approval202202180
- MFDS drugKwangdong Eneric tab.2022-03-28Drug · OTC · Approval202201218
- MFDS drugKwangdong Meposita tab. 50/850mg2022-01-19Drug · Prescription · Approval202200316
- MFDS drugKwangdong Meposita tab. 50/500mg2022-01-19Drug · Prescription · Approval202200317
- MFDS drugKwangdong Meposita tab. 50/1000mg2022-01-19Drug · Prescription · Approval202200318
- MFDS drugSunhana tab.2021-12-03Drug · OTC · Notification202107800
- MFDS drugKwangdong Piroen soft extract2021-11-10Drug · OTC · Notification202107393
- MFDS drugHardicol Max Tab.2021-08-25Drug · OTC · Notification202106150
- MFDS drugKwangdong Empaglo tab. 25mgRevoked2021-07-29Drug · Prescription · Approval202105607
- MFDS drugKwangdong Empaglo tab. 10mgRevoked2021-07-29Drug · Prescription · Approval202105608
- MFDS drugDualFamo tab.2021-07-09Drug · OTC · Notification202105229
- MFDS drugRinello tab.15mgRevoked2021-03-16Drug · Prescription · Approval202102368
- MFDS drugRinello tab.10mgRevoked2021-03-16Drug · Prescription · Approval202102369
- MFDS drugSolpyo Woo Hwang Chung Sim Won Liquid(including L-Muscone instead of Musk)Revoked2021-01-04Drug · OTC · Notification202100019
- MFDS drugKwangdong Albendazole Tab.Revoked2020-11-26Drug · OTC · Notification202008246
- MFDS drugQ-Acne Plus Cream2020-11-16Drug · OTC · Notification202007900
- MFDS drugHyalsix Inj.2020-10-30Drug · Prescription · Approval202007475
- MFDS drugEYETOK CARE Eye Drops (single use)Revoked2020-10-15Drug · OTC · Notification202007061
- MFDS drug네비레트엠정1.25밀리그램(네비보롤염산염)2020-09-28Drug · Prescription · Approval202006679
- MFDS drug네비레트엠정5밀리그램(네비보롤염산염)2020-09-28Drug · Prescription · Approval202006680
- MFDS drug네비레트엠정2.5밀리그램(네비보롤염산염)2020-09-28Drug · Prescription · Approval202006681
- MFDS drugSolpyo Woohwangchungsimwon Sol. (replace Musk, include L-Muscone)2020-08-10Drug · OTC · Notification202005722
- MFDS drug로제케이정10/5밀리그램2020-06-23Drug · Prescription · Approval202004560
- MFDS drug로제케이정10/10밀리그램2020-06-23Drug · Prescription · Approval202004561
- MFDS drug로제케이정10/20밀리그램2020-06-23Drug · Prescription · Approval202004562
- MFDS drugKwangdong Livershot Tab. 3002020-06-19Drug · OTC · Approval202004494
- MFDS drugJanulow-D Tab. 25mg2020-05-29Drug · Prescription · Approval202004046
- MFDS drugJanulow-D Tab. 50mg2020-05-29Drug · Prescription · Approval202004047
- MFDS drugJanulow-D Tab. 100mg2020-05-29Drug · Prescription · Approval202004048
- MFDS drug장이락캡슐(바실루스리케니포르미스균)2020-05-29Drug · OTC · Notification202004112
- MFDS drugJangi Lac Powder2020-05-26Drug · OTC · Notification202003864
- MFDS drugErinitor Tab. 5mg2020-03-31Drug · Prescription · Approval202002237
- MFDS drugSencodyl F Tab.2020-02-05Drug · OTC · Notification202000645
- MFDS drug광동탕엠액2019-12-26Drug · OTC · Notification201908635
- MFDS drug티보리시정2.5밀리그램(티볼론)2019-12-19Drug · Prescription · Approval201908527
- MFDS drugAmipartybag Inj. 5%2019-12-11Drug · Prescription · Notification201908353
- MFDS drug뮤아렌정(에페리손염산염)Revoked2019-10-28Drug · Prescription · Approval201907489
- MFDS drug광동알디액2019-10-18Drug · OTC · Notification201907347
- MFDS drug비타민디3본주100,000IU(콜레칼시페롤)Revoked2019-09-18Drug · Prescription · Notification201906532
- MFDS drug비타민디3본주300,000IU(콜레칼시페롤)Revoked2019-09-18Drug · Prescription · Notification201906533
- MFDS drug평위천프라임액2019-09-17Drug · OTC · Notification201906489
Showing the 80 most recent of 323 records.
Clinical trials
data.go.kr29 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 22 · Phase 1 4 · Phase 3 2 · Phase 2 1)
- BioequivalenceKD-R1122026-05-28
1 trial site
- BioequivalenceKD-R1112025-08-20
1 trial site
- BioequivalenceKD-R1102025-03-27
1 trial site
- BioequivalenceKD-R109T2024-04-29
1 trial site
- Bioequivalence아디펙스정(펜터민염산염)2023-04-06
2 trial sites
- BioequivalenceKD-R105T2022-12-06
1 trial site
- BioequivalenceKD-R201T2022-09-29
1 trial site
- Bioequivalence알렌시캡슐125밀리그램2022-02-14
1 trial site
- Phase 3Vyleesi 주사제2020-05-22
14 trial sites
- Bioequivalence넥소닙정200밀리그램2020-04-24
2 trial sites
- Bioequivalence광동네비보롤염산염정5밀리그램(네비보롤염산염)2019-09-11
2 trial sites
- Bioequivalence광동아토르바스타틴정20밀리그램(아토르바스타틴칼슘삼수화물)2018-07-17
2 trial sites
Show 17 more
- Bioequivalence광동에베로리무스정5mg(가칭)2017-03-09
2 trial sites
- Bioequivalence에이덱스정(아나스트로졸)2017-01-17
2 trial sites
- Phase 2KD101 연질캡슐 200mg2016-10-27
10 trial sites
- Bioequivalence레날리도마이드25mg2016-10-11
2 trial sites
- Bioequivalence광동에베로리무스정(가칭)2016-08-23
2 trial sites
- Phase 1KD101 연질캡슐 200mg, 50mg2014-11-27
1 trial site
- Bioequivalence광동타다라필구강붕해필름10밀리그램 (Tadalafil 10mg)2014-11-20
2 trial sites
- Phase 1광동타다라필구강붕해필름20mg2014-06-10
1 trial site
- Bioequivalence광동타다라필구강붕해필름20mg (Tadalafil 20mg)2014-05-27
2 trial sites
- Phase 3비타민D3비오엔주(콜레칼시페롤)2013-11-13
3 trial sites
- Bioequivalence광동로라타딘구강붕해필름2013-07-31
1 trial site
- Phase 1KD101 연질캡슐 200mg2013-07-17
1 trial site
- Bioequivalence알도셉트구강붕해필름 10밀리그램(도네페질염산염)2013-05-30
1 trial site
- Bioequivalence광동타목시펜정2013-05-15
2 trial sites
- Bioequivalence광동타목시펜정20밀리그램2013-05-15
2 trial sites
- Bioequivalence광동테가푸르/기메라실/오테라실캡슐2012-10-08
- Phase 1KD-ODF-012012-01-12
1 trial site
Companies approved for the same productsPharma & CDMO
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Aprogen Biologics develops Remicade, Rituxan, and Herceptin biosimilars and operates a world top-5 scale antibody production facility.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.
Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.
Founded in 1996 and listed on KOSDAQ in 1999, ChoA Pharmaceutical is an OTC-focused drugmaker exporting to 23 countries worldwide.
Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.
Founded in 1998, Kyungnam Pharm is a pharmaceutical and health-food company known for the vitamin brand Lemona and placenta drink Jahasaengryeok.
Vivozon Pharmaceutical, founded in 2002 and KOSDAQ-listed in 2005, makes ETC/OTC drugs and runs CMO/OEM businesses across about 190 items.
Founded in 1926 and listed on the KOSPI in 1962, Yuhan Corporation is a comprehensive pharmaceutical company known for its innovative drug Leclaza.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition